Shancheng Ren
- Molecular Biology top 5%
- Cancer Research top 1%
- Pulmonary and Respiratory Medicine top 2%
- Oncology top 5%
- Immunology top 10%
- Topics
- Prostate Cancer Treatment and Research (32 papers)Prostate Cancer Diagnosis and Treatment (22 papers)Cancer-related molecular mechanisms research (14 papers)
- Journals
- NatureNature GeneticsPLoS ONE
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Shancheng Ren
72 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Molecular Biology 2.1k
- Cancer Research 1.4k
- Pulmonary and Respiratory Medicine 992
- Oncology 895
- Immunology 391
Countries citing papers authored by Shancheng Ren
This map shows the geographic impact of Shancheng Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shancheng Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shancheng Ren more than expected).
Fields of papers citing papers by Shancheng Ren
This network shows the impact of papers produced by Shancheng Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shancheng Ren. The network helps show where Shancheng Ren may publish in the future.
Co-authorship network of co-authors of Shancheng Ren
This figure shows the co-authorship network connecting the top 25 collaborators of Shancheng Ren. A scholar is included among the top collaborators of Shancheng Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shancheng Ren. Shancheng Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 9 | |
| 8 | 3 | |
| 9 | 5 | |
| 10 | 21 | |
| 11 | 38 | |
| 12 | 46 | |
| 13 | 32 | |
| 14 | 8 | |
| 15 | Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillancebreakdown → | 736 |
| 16 | 11 | |
| 17 | 28 | |
| 18 | 2 | |
| 19 | 271 | |
| 20 | 167 |
About Shancheng Ren
Shancheng Ren is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 78 papers that have together received 3.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (32 papers), Prostate Cancer Diagnosis and Treatment (22 papers) and Cancer-related molecular mechanisms research (14 papers). The work is most often cited by research in Cancer Research (1.4k citations), Oncology (895 citations) and Pulmonary and Respiratory Medicine (992 citations). Shancheng Ren has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Yinghao Sun, Fubo Wang, Chuanliang Xu, Xu Gao, Yasheng Zhu, Ji Lu, Min Wei, Yinghao Sun, Yu‐Tian Xiao and Wenyi Wei. Their work appears in journals such as Nature, Nature Genetics and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.